Bk-Virus Nephropathy disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

BKN MCID: BKV001 MIFTS: 22	Bk-Virus Nephropathy (BKN) Categories: Nephrological diseases, Rare diseases
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Bk-Virus Nephropathy

MalaCards integrated aliases for Bk-Virus Nephropathy:

Name: Bk-Virus Nephropathy ²⁰

Bk Virus Nephropathy ²⁰ ⁷¹

Nephropathy from Bk Virus ²⁰

Polyomavirus Nephropathy ²⁰

Bkn ²⁰

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Nephrological diseases

See all MalaCards categories (disease lists)

External Ids:

UMLS ⁷¹ C1697878

Sources

Summaries for Bk-Virus Nephropathy

MalaCards based summary : Bk-Virus Nephropathy, also known as bk virus nephropathy, is related to interstitial nephritis and polyomavirus-associated nephropathy. An important gene associated with Bk-Virus Nephropathy is HLA-E (Major Histocompatibility Complex, Class I, E). The drugs Everolimus and Mycophenolic acid have been mentioned in the context of this disorder. Affiliated tissues include kidney, pancreas and t cells.

Sources

Related Diseases for Bk-Virus Nephropathy

Diseases in the C1q Nephropathy family:

Bk-Virus Nephropathy

Diseases related to Bk-Virus Nephropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 64)

#	Related Disease	Score
1	interstitial nephritis	10.4
2	polyomavirus-associated nephropathy	10.4
3	cystitis	10.4
4	end stage renal disease	10.3
5	hemorrhagic cystitis	10.2
6	glomerulonephritis	10.2
7	iga glomerulonephritis	10.2
8	myelodysplastic syndrome	10.2
9	proteinuria, chronic benign	10.2
10	human cytomegalovirus infection	10.2
11	leukemia, chronic lymphocytic	10.0
12	vesicoureteral reflux 1	10.0
13	type 1 diabetes mellitus	10.0
14	hypertensive nephropathy	10.0
15	peripartum cardiomyopathy	10.0
16	disease by infectious agent	10.0
17	epstein-barr virus hepatitis	10.0
18	exanthem	10.0
19	diffuse large b-cell lymphoma	10.0
20	cardiac arrest	10.0
21	lymphoproliferative syndrome	10.0
22	polycystic kidney disease	10.0
23	neuroretinitis	10.0
24	endocarditis	10.0
25	meningoencephalitis	10.0
26	alport syndrome	10.0
27	hydronephrosis	10.0
28	pyelonephritis	10.0
29	pancytopenia	10.0
30	acute kidney tubular necrosis	10.0
31	dilated cardiomyopathy	10.0
32	uveitis	10.0
33	histoplasmosis	10.0
34	pulmonary tuberculosis	10.0
35	adenocarcinoma	10.0
36	retinitis	10.0
37	skin disease	10.0
38	bladder adenocarcinoma	10.0
39	rapidly progressive glomerulonephritis	10.0
40	proliferative glomerulonephritis	10.0
41	mesangial proliferative glomerulonephritis	10.0
42	kidney disease	10.0
43	progressive multifocal leukoencephalopathy	10.0
44	b-cell lymphoma	10.0
45	chronic kidney disease	10.0
46	herpes simplex	10.0
47	chickenpox	10.0
48	molluscum contagiosum	10.0
49	iridocyclitis	10.0
50	meningitis	10.0

Graphical network of the top 20 diseases related to Bk-Virus Nephropathy:

Sources

Symptoms & Phenotypes for Bk-Virus Nephropathy

Sources

Drugs & Therapeutics for Bk-Virus Nephropathy

Drugs for Bk-Virus Nephropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Everolimus

Approved

Phase 4

159351-69-6

6442177 70789204

Synonyms:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

001, RAD

07741_FLUKA

159351-69-6

40-O-(2-hydroxyethyl)-rapamycin

40-O-(2-Hydroxyethyl)-rapamycin

42-O-(2-Hydroxyethyl)rapamycin

Afinitor

Certican

CERTICAN(R)

CHEMBL1201755

D02714

DB01590

everolimus

Everolimus

évérolimus

Everolimus (JAN/USAN/INN)

Everolimus [USAN]

LS-143292

MolPort-003-847-342

MolPort-003-925-588

NCGC00167512-01

NVP-RAD-001

RAD 001

RAD, SDZ

RAD001

RAD-001

RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus

RAD-001C

S1120_Selleck

SDZ RAD

SDZ-RAD

UNII-9HW64Q8G6G

Zortress

Mycophenolic acid

Approved

Phase 4

24280-93-1

446541

Synonyms:

(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate

(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid

Acid, mycophenolic

Acide mycophenolique

Acido micofenolico

Acidum mycophenolicum

Cellcept

Melbex

Micofenolico acido

Mofetil hydrochloride, mycophenolate

Mofetil, mycophenolate

Mycophenoic acid

Mycophenolate

Mycophenolate mofetil

Mycophenolate mofetil hydrochloride

Mycophenolate sodium

Mycophenolate, sodium

Mycophenolic acid

Mycophenolic acid morpholinoethyl ester

Mycophenolsaeure

Mycophenolsäure

Myfortic

Sodium mycophenolate

Immunosuppressive Agents

Phase 4

Immunologic Factors

Phase 4

Cyclosporins

Phase 4

Cidofovir

Approved

Phase 1, Phase 2

113852-37-2

60613

Synonyms:

({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid

({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid

(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine

(S)-(3-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonate

(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid

(S)-(3-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid

(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine

(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine

(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine

(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid

(S)-HPMPC

[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid

[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonate

[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid

[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine

1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine

1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine

1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine

1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate

113852-37-2

120362-37-0 (hydrochloride salt)

149394-66-1

AC-1666

AC1L1TLB

AC1Q6C68

AKOS005145721

C8H14N3O6P

CDV

CHEBI:3696

CHEMBL152

CID60613

Cidofovir

Cidofovir (anhydrous)

Cidofovir (Vistide)

Cidofovir anhydrous

Cidofovir sodium

Cidofovir, (+-)-isomer

Cidofovir, (R)-isomer

Cidofovir, sodium salt

Cidofovirum

DB00369

Forvade

GS 0504

GS 504

GS-0504

GS504

GS-504

HPMPC

HSDB 7115

LS-106432

MolPort-005-935-597

NSC742135

S1516_Selleck

UNII-768M1V522C

Vistide

Vistide, Cidofovir

Anti-Infective Agents

Phase 1, Phase 2

Antiviral Agents

Phase 1, Phase 2

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia After Reduction of Immunosuppression Alone vs. Reduction of Immunosuppression and Replacement of Mycophenolate Mofetil by Everolimus	Recruiting	NCT03216967	Phase 4	everolimus
2	Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Dosing Interval, 3-period Study of the Safety, Tolerability and Effectiveness of Adoptively Transferred Viralym-M (ALVR105) Multivirus-specific T Cells in Kidney Transplant Recipients With Either High or Low Levels of BK Viremia	Recruiting	NCT04605484	Phase 2
3	A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy	Terminated	NCT00138424	Phase 1, Phase 2	Cidofovir;Placebo
4	A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of Allograft-threatening BK Virus Infection in Kidney Transplant Recipients	Withdrawn	NCT03456999	Phase 2
5	Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant	Completed	NCT02049827
6	Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation	Not yet recruiting	NCT04506060
7	BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study	Withdrawn	NCT02758288

Search NIH Clinical Center for Bk-Virus Nephropathy

Sources

Genetic Tests for Bk-Virus Nephropathy

Sources

Anatomical Context for Bk-Virus Nephropathy

MalaCards organs/tissues related to Bk-Virus Nephropathy:

⁴⁰

Kidney, Pancreas, T Cells, Bone Marrow

Sources

Publications for Bk-Virus Nephropathy

Articles related to Bk-Virus Nephropathy:

(show top 50) (show all 267)

#	Title	Authors	PMID	Year
1	The role of donor-derived cell-free DNA in the detection of renal allograft injury. ⁶¹	Zhou Y...Jiang T	33454228	2021
2	BK virus nephropathy in a heart transplant recipient. ⁶¹	Nieto-Rios JF...Serna-Higuita LM	33527977	2021
3	Validation of a noninvasive prognostic signature for allograft failure following BK virus associated nephropathy. ⁶¹	Abuhelaiqa E...Dadhania DM	33349997	2020
4	Intragraft gene expression in native kidney BK virus nephropathy versus T cell-mediated rejection: Prospects for molecular diagnosis and risk prediction. ⁶¹	Adam BA...Mengel M	32372431	2020
5	Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients. ⁶¹	Odum JD...Warady BA	32556543	2020
6	Use of Leflunomide as an Antiviral Agent with Everolimus for BK Virus Nephropathy Patients After Kidney Transplantation: A Case Series. ⁶¹	Yamazaki T...Tojimbara T	33235184	2020
7	Investigating Risk Factors for the Development of BK Virus Infection in Kidney Transplant Recipients in Guilan Province during 2007-2015. ⁶¹	Khosravi M...Mokhtari G	33084004	2020
8	Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients. ⁶¹	Moon J...Min DI	32323406	2020
9	The Importance of Kidney Medullary Tissue for the Accurate Diagnosis of BK Virus Allograft Nephropathy. ⁶¹	Nankivell BJ...Khan A	32601093	2020
10	Characterization of aberrant pathways activation and immune microenviroment of BK virus associated nephropathy. ⁶¹	Liu Y...Zhao M	32668411	2020
11	Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study. ⁶¹	Bussalino E...Paoletti E	32533451	2020
12	Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents. ⁶¹	Leeaphorn N...Cheungpasitporn W	31765056	2020
13	SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury. ⁶¹	Menon R...Kretzler M	32511461	2020
14	The Pathophysiology and Impact of Inflammation in Nonscarred Renal Interstitium: The Banff i Lesion. ⁶¹	Nankivell BJ...Chapman JR	31369519	2020
15	BK virus nephropathy without haemorrhagic cystitis following bone marrow transplantation. ⁶¹	Ghinai R...Moppett J	31621066	2020
16	BK Virus Nephropathy: Prevalence, Impact and Management Strategies. ⁶¹	Sharma R...Zachariah M	32821148	2020
17	Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. ⁶¹	Rohan V...Bratton C	30501589	2019
18	Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study. ⁶¹	Kwon H...Korean Organ Transplantation Registry Study Group	31796812	2019
19	Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study. ⁶¹	Ji J...Zhang X	30995893	2019
20	Identification of BK Virus Genotypes in Recipients of Renal Transplant in Vietnam. ⁶¹	Toan PQ...Su HX	31477425	2019
21	Simultaneous cytomegalovirus glomerulitis and BK virus nephropathy leading to kidney allograft loss. ⁶¹	Moktefi A...Grimbert P	31470994	2019
22	Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy. ⁶¹	Gniewkiewicz MS...Durlik M	31389404	2019
23	HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant. ⁶¹	Rohn H...Rebmann V	31394776	2019
24	Native kidney BK virus nephropathy, a systematic review. ⁶¹	Shah A...Hogan JJ	30907978	2019
25	Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. ⁶¹	Abeling T...Gwinner W	29860340	2019
26	Surgical Complications After Pediatric Renal Transplant. ⁶¹	Sozen H...Dalgic A	28128720	2019
27	Successful Treatment for BK Virus Nephropathy by Leflunomide in a Kidney Transplant Patient: A Case Report. ⁶¹	Wu MY...Wu MS	31084921	2019
28	Do Antithymocyte Globulin-Free Acute Rejection Therapies Increase the Risk of Polyoma Nephropathy in Renal Transplant Recipients? ⁶¹	Gunay E...Toz H	31101182	2019
29	Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients. ⁶¹	Aliyeva N...Turkmen A	31101184	2019
30	CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation. ⁶¹	Fan Y...Shi B	30707648	2019
31	Monoclonal immunoglobulin G deposits on tubular basement membrane in renal allograft: is this significant for chronic allograft injury? ⁶¹	Sawada A...Nitta K	30124906	2019
32	Higher Incidence of BK Virus Nephropathy in Pediatric Kidney Allograft Recipients with Alport Syndrome. ⁶¹	Cho YH...Kang HG	30978953	2019
33	Bladder Carcinoma Associated with BK Virus in a Renal Allograft Recipient. ⁶¹	Gaur L...Rana DS	30983757	2019
34	BK virus nephropathy and multiorgan involvement in a child with heart transplantation . ⁶¹	Lee Y...Cho H	30526816	2019
35	The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy. ⁶¹	Chen XT...Huang G	30737303	2019
36	Native kidney BK nephropathy: A case report. ⁶¹	Al Zein S...Kaur G	30847205	2019
37	A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring. ⁶¹	Sigdel TK...Sarwal MM	31365568	2019
38	Clinical Significance of Renal Allograft Protocol Biopsies: A Single Tertiary Center Experience in Malaysia. ⁶¹	Fu MS...Ng KP	31186948	2019
39	Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients. ⁶¹	Zakaria ZE...Al-Otaibi T	30777529	2019
40	Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies. ⁶¹	Itabashi Y...Shishido S	30777522	2019
41	BK Virus Nephropathy. ⁶¹	Sawinski D...Trofe-Clark J	30242026	2018
42	BK Virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India. ⁶¹	Gupta P...Rana DS	30588968	2018
43	Abnormalities in Protocol Graft Kidney Biopsy 6 Months Posttransplantation in a Tertiary Care Center Hospital of Nepal. ⁶¹	Shrestha M...Kafle MP	30316361	2018
44	BK virus-induced renal allograft nephropathy. ⁶¹	Krejci K...Zadrazil J	29765170	2018
45	Prevalence of BK virus among renal transplant recipients in a tertiary care hospital in Sri Lanka ⁶¹	Premathilake MI...Lanerolle RD	30415516	2018
46	Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients. ⁶¹	Imlay H...Limaye AP	29809315	2018
47	Fluoroquinolones and BK Virus Nephropathy: A Myth or a Reality. ⁶¹	Khalil MAM...Khan TFT	30158742	2018
48	The utility of surveillance biopsies in pediatric kidney transplantation. ⁶¹	Dharnidharka VR...Hmiel SP	29260318	2018
49	Urine biomarkers informative of human kidney allograft rejection and tolerance. ⁶¹	Nissaisorakarn V...Suthanthiran M	29366869	2018
50	Aryl hydrocarbon receptor expression by macrophages and lymphocytes within infiltrates in BK polyomavirus associated nephropathy. ⁶¹	Bouatou Y...Florquin S	29305091	2018

Sources

Genes for Bk-Virus Nephropathy

Genes related to Bk-Virus Nephropathy (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	HLA-E	Major Histocompatibility Complex, Class I, E	Protein Coding	7.02	GeneCards inferred via : Publications (show sections)

Sources

Variations for Bk-Virus Nephropathy

Sources

Expression for Bk-Virus Nephropathy

Search GEO for disease gene expression data for Bk-Virus Nephropathy.

Sources

Pathways for Bk-Virus Nephropathy

Sources

GO Terms for Bk-Virus Nephropathy

Sources

Sources for Bk-Virus Nephropathy

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Mar-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Bk-Virus Nephropathy (BKN)

Aliases & Classifications for Bk-Virus Nephropathy

MalaCards integrated aliases for Bk-Virus Nephropathy:

Classifications:

External Ids:

Summaries for Bk-Virus Nephropathy

Related Diseases for Bk-Virus Nephropathy

Diseases in the C1q Nephropathy family:

Diseases related to Bk-Virus Nephropathy via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Bk-Virus Nephropathy:

Symptoms & Phenotypes for Bk-Virus Nephropathy

Drugs & Therapeutics for Bk-Virus Nephropathy

Drugs for Bk-Virus Nephropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Genetic Tests for Bk-Virus Nephropathy

Anatomical Context for Bk-Virus Nephropathy

MalaCards organs/tissues related to Bk-Virus Nephropathy:

Publications for Bk-Virus Nephropathy

Articles related to Bk-Virus Nephropathy:

Genes for Bk-Virus Nephropathy

Genes related to Bk-Virus Nephropathy (0 elite genes):

Variations for Bk-Virus Nephropathy

Expression for Bk-Virus Nephropathy

Pathways for Bk-Virus Nephropathy

GO Terms for Bk-Virus Nephropathy

Sources for Bk-Virus Nephropathy